AMPX Stock: Amprius Technologies Triples Revenue While Analysts Set $20 Price Target

Key Takeaways

• AMPX stock has surged over 100% from its 2025 lows but recently pulled back 8.9% in a single session — is the silicon-anode battery leader just getting started or running out of charge?
• Verdict: Buy on pullbacks. Amprius Technologies’ fundamentals are inflecting sharply, with revenue tripling and a clear path to profitability. Near-term volatility offers accumulation opportunities.
• Full-year 2025 revenue hit $73 million (up 202% year-over-year), Q4 gross margin reached 24%, and the company posted its first positive quarterly adjusted EBITDA of $1.8 million.
• Bull case: 2026 guidance of $125M+ revenue (70%+ growth), $21M China EV order opens massive new TAM, and all 9 covering analysts rate AMPX a Strong Buy with a $20 median target.
• Bear case: Still unprofitable on a GAAP basis, heavy reliance on contract manufacturers, and the stock trades at roughly 2x forward revenue for a company that has yet to prove sustained profitability at scale.

What Is Amprius Technologies?

Amprius Technologies, Inc. (NYSE: AMPX) develops, manufactures, and markets next-generation lithium-ion batteries using proprietary silicon-anode technology. Unlike conventional graphite-anode cells, Amprius’ batteries achieve energy densities exceeding 400 Wh/kg — and its flagship cell won a CES 2026 Innovation Award for delivering 520 Wh/kg, more than double the energy density of many standard lithium-ion batteries at equivalent weight. This performance advantage makes Amprius’ cells critical for applications where weight and range matter most: unmanned aerial vehicles (UAVs), electric vertical takeoff and landing aircraft (eVTOL), defence platforms, and increasingly, light electric vehicles.

The AMPX stock price currently sits near $17 after a volatile March that saw the stock surge 17% on earnings day before giving back gains in a broader market selloff. Founded in 2008 and headquartered in Fremont, California, Amprius operates a manufacturing-light model that leverages contract manufacturing partners in Asia and, as of February 2026, a new domestic partnership with Nanotech Energy to serve NDAA-compliant defence customers including L3Harris. The company’s global manufacturing capacity now exceeds 2.0 GWh, positioning it to capture demand across aviation, defence, and the emerging light EV market in China.

Recent AMPX Stock Price Performance

The AMPX stock price analysis reveals a company in the middle of a high-conviction inflection point, with price action reflecting both the excitement and the uncertainty that comes with scaling a hardware startup. AMPX surged 17.4% on March 5, 2026 after reporting Q4 2025 results that beat expectations across the board — revenue of $25.2 million topped the $22.9 million consensus, while the EPS loss of $0.01 came in well ahead of the $0.04 loss analysts had modelled.

But the gains proved short-lived. By late March, AMPX had pulled back sharply, falling 8.9% on March 30 alone and 6.3% on March 27. The selloffs were not driven by company-specific bad news but rather by broader market risk-off sentiment, insider selling disclosures, and profit-taking after the post-earnings spike. AMPX remains up significantly from its sub-$8 levels in mid-2025, but the stock has been volatile: it peaked near $20 in early March before retreating to the mid-teens.

For context, Amprius was recognised by TIME as one of America’s Top GreenTech Companies for 2026 on March 26 — the same week the stock dropped nearly 15%. That disconnect between fundamental recognition and price action is characteristic of small-cap growth stocks where institutional positioning and macro sentiment often override near-term news flow.

AMPX Valuation Analysis

Valuing Amprius requires accepting that traditional earnings-based metrics are largely irrelevant for a pre-profit company in hyper-growth mode. The more useful lens is revenue trajectory, path to profitability, and how the market is pricing that transition relative to peers in the advanced battery space.

Metric	AMPX (FY2025)	2026 Guidance
Revenue	$73.0M	$125M+
Revenue Growth (YoY)	202%	70%+
Q4 Gross Margin	24%	Expanding
Net Loss (GAAP)	-$44.0M*	Below -$8M
Adj. Net Loss (ex-impairment)	-$21.5M	—
Adj. EBITDA (Q4)	+$1.8M	$4M+
EV/Revenue (Forward)	—	~2x
Analyst Fair Value (SimplyWallSt)	—	$19.25

*Includes $22.5M one-time impairment charge related to a terminated Colorado manufacturing facility.

At roughly $17 per share and a market capitalisation near $1.7 billion, AMPX trades at approximately 2x its 2026 guided revenue of $125 million. For a company growing revenue at 70%+ with improving margins and a path to EBITDA profitability, that multiple is reasonable — neither screaming bargain nor obviously expensive. Peers in the next-generation battery space like Enovix stock price trade at comparable or higher multiples with less revenue traction. The key question is not whether the current valuation is cheap, but whether Amprius can execute on its manufacturing scale-up without the margin erosion that has plagued other battery startups.

Bull Case vs Bear Case for AMPX Stock

Catalyst	Why Bulls Buy Here	Why Bears Stay Cautious
Revenue Growth	Revenue tripled in 2025 to $73M; 2026 guidance of $125M+ implies 70%+ growth with improving visibility	Growth requires flawless execution across multiple contract manufacturers in Asia and the U.S.
China Light EV Order	$21M purchase order from new Chinese customer opens a massive addressable market beyond aviation	Geopolitical risk: China-facing revenue creates NDAA compliance complications and tariff exposure
Profitability Path	First positive quarterly adj. EBITDA ($1.8M in Q4); 2026 guides to full-year positive adj. EBITDA of $4M+	Still GAAP unprofitable with -$44M net loss in 2025; path to sustained profitability unproven at scale
Nanotech Partnership	U.S.-based manufacturing enables NDAA-compliant supply chain for defence customers like L3Harris	Partnership is early stage; domestic manufacturing costs may compress margins vs. Asian production
Analyst Consensus	9/9 analysts rate Strong Buy; unanimous bullish consensus is rare and reflects deep conviction	Small analyst coverage universe (9 analysts) means consensus can shift quickly on a single downgrade

Why Is AMPX Stock Down Recently?

Despite overwhelmingly positive fundamentals, AMPX has pulled back roughly 15% from its early March highs. Several factors explain the disconnect. First, the stock surged 17% in a single session on earnings day, creating a natural profit-taking opportunity for short-term traders. Second, insider selling disclosures in late March — a routine but optically negative event — gave cautious investors a reason to trim. Third, the broader small-cap growth sector has been under pressure as tariff fears and macro uncertainty push capital toward safer assets.

Importantly, none of the recent declines reflect a deterioration in Amprius’ business trajectory. The company continues to win new orders, expand manufacturing capacity, and move toward profitability faster than analysts expected. The negative net margin of 60.3% and return on equity of -24.3% reflect a company still investing heavily in scale-up — metrics that should improve meaningfully if 2026 guidance is met. For investors with a 12–24 month horizon, the pullback looks more like opportunity than warning sign.

Analyst Price Targets for AMPX Stock

The analyst community is unanimously bullish on Amprius Technologies. All 9 covering analysts rate AMPX a Strong Buy, with a median price target of $20.00 — implying roughly 18% upside from current levels. The target range spans from $18 to $22, with no Hold or Sell ratings in the coverage universe.

Christopher Souther at B. Riley Securities holds the Street-high target of $22, raised from $16 on March 9, 2026 following the Q4 earnings beat. Souther cites Amprius’ accelerating revenue trajectory and improving margin profile as key drivers, with the $21M China light EV order representing a potential step-change in the company’s addressable market. His $22 target implies roughly 29% upside from current prices.

Cantor Fitzgerald raised its target from $16 to $20 with an Overweight rating on March 6, 2026, highlighting execution on the manufacturing scale-up and the strategic value of the Nanotech Energy partnership for NDAA-compliant defence supply chains. Craig-Hallum similarly lifted its target from $17 to $21, while Roth Capital moved from $16 to $20 — all on the back of Q4 results.

The unanimity of the upgrades is notable. When four analysts independently raise targets by 25–38% within the same week, it signals a genuine reassessment of the company’s growth trajectory rather than routine maintenance of existing models. For investors asking whether AMPX is a buy, the Street’s answer is a resounding yes — with the caveat that small-cap battery stocks carry inherent execution risk.

The Silicon-Anode Advantage and TAM Expansion

What separates Amprius from the crowded field of battery startups is that its technology is already in production and generating meaningful revenue — not stuck in the lab. The company’s silicon-anode cells deliver 2x the energy density of conventional lithium-ion at comparable weight, a performance edge validated by its CES 2026 Innovation Award and by paying customers across aviation, defence, and now light electric vehicles.

The $21 million purchase order from a Chinese electric mobility customer announced in early 2026 is strategically significant because it marks Amprius’ entry into a mass-market segment. Aviation and defence orders tend to be high-margin but low-volume; electric scooters, three-wheelers, and motorcycles in China represent a market measured in tens of millions of units annually. If the initial order leads to repeat business and expanded adoption, it could transform Amprius from a niche supplier into a volume player. This is similar to the trajectory that companies like Tesla stock price followed — starting in premium segments before scaling into mass markets.

The Nanotech Energy partnership, announced in February 2026, adds another dimension. By establishing U.S.-based manufacturing, Amprius can serve NDAA-compliant defence programs — a growing market as the Pentagon prioritises domestic supply chains for critical technologies. The partnership supports production of the SA128 silicon-anode cell and enables Amprius to serve customers like L3Harris stock price without the geopolitical complications of relying solely on Asian manufacturing.

FAQ

Is AMPX stock a good investment in 2026?

The investment case for AMPX is strong but comes with typical early-growth-stage risks. Revenue tripled to $73 million in 2025, 2026 guidance calls for $125 million+ (70%+ growth), and the company achieved its first positive quarterly adjusted EBITDA. All 9 covering analysts rate it Strong Buy with a $20 median target. The stock is best suited for investors with a higher risk tolerance and a multi-year time horizon who can weather the volatility inherent in small-cap hardware companies.

Why is AMPX stock down after strong earnings?

AMPX pulled back roughly 15% from its post-earnings highs due to profit-taking after a 17% single-day surge, insider selling disclosures, and broader small-cap growth stock weakness. None of these factors reflect deterioration in the company’s business fundamentals. Revenue beat estimates by 10%, EPS beat by $0.03, and 2026 guidance exceeded expectations.

What is Amprius Technologies’ competitive advantage?

Amprius’ core advantage is its silicon-anode battery technology, which delivers energy densities of 400–520 Wh/kg — roughly double what conventional lithium-ion cells achieve. This performance edge is validated by production contracts (not just lab results), a CES 2026 Innovation Award, and adoption by defence and aviation customers. The manufacturing-light model using contract partners in Asia and the U.S. allows Amprius to scale capacity without the massive capex burden that has sunk other battery startups.

What does the $21 million China order mean for AMPX?

The $21 million purchase order from a Chinese electric mobility customer for SiCore cylindrical cells represents Amprius’ first major entry into the light electric vehicle market — specifically scooters, three-wheelers, and motorcycles. This segment is vastly larger in volume than aviation and defence, and if the relationship expands, it could meaningfully diversify Amprius’ revenue base and accelerate the path to sustained profitability. It also validates the commercial viability of Amprius’ technology beyond premium niche applications.

What are the biggest risks for AMPX stock?

The primary risks include execution risk on manufacturing scale-up across multiple contract partners, continued GAAP losses despite improving unit economics, geopolitical exposure from China-facing revenue and Asian manufacturing, and the small analyst coverage universe that makes the consensus vulnerable to shifts. Additionally, Amprius competes against well-funded peers like Enovix stock price platforms and established battery giants like CATL and LG Energy Solution, who are also investing in silicon-anode technology. If a larger competitor cracks the manufacturing challenge at lower cost, Amprius’ technology lead could narrow.

Disclaimer

This article is for informational purposes only and does not constitute financial advice or a recommendation to buy or sell securities. Past performance does not guarantee future results. Investors should conduct thorough due diligence and consult qualified financial advisors before making investment decisions.

MEXC is a global cryptocurrency exchange committed to “MEXCmize Your Opportunities.” Serving over 40 million users across 170+ countries, MEXC offers access to more than 3,000 digital assets across spot and derivatives markets. Known for its high liquidity and broad selection of trending tokens, the platform is designed to support both new traders and experienced investors. MEXC also continues to enhance trading efficiency through innovations such as zero-fee trading, while prioritizing a secure, user-friendly, and accessible trading experience.